These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3373489)

  • 1. Synthesis of ethyl 2-(4-chlorophenyl)-5-(2-furyl)-4-oxazoleacetate, a hypolipidemic agent, and related compounds.
    Moriya T; Seki M; Takabe S; Matsumoto K; Takashima K; Mori T; Odawara A; Takeyama S
    J Med Chem; 1988 Jun; 31(6):1197-204. PubMed ID: 3373489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and hypolipidemic activities of 5-thienyl-4-oxazoleacetic acid derivatives.
    Moriya T; Takabe S; Maeda S; Matsumoto K; Takashima K; Mori T; Takeyama S
    J Med Chem; 1986 Mar; 29(3):333-41. PubMed ID: 3950914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 5-alkyl-4-oxazoleacetic acid derivatives with hypolipidemic activities.
    Seki M; Moriya T; Matsumoto K; Takashima K; Mori T; Odawara A; Takeyama S
    Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4435-40. PubMed ID: 3246011
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and hypolipidemic activity of 2-substituted isobutyric acid derivatives.
    Morishita S; Saito T; Hirai Y; Shoji M; Mishima Y; Kawakami M
    J Med Chem; 1988 Jun; 31(6):1205-9. PubMed ID: 3163736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of 3,5-isoxazolidinediones as hypolipidemic agents in rodents.
    Woodard T; Debnath ML; Simlot R; Izydore RA; Daniels DL; Wong OT; ElSourady H; Hall IH
    Pharm Res; 1995 Jan; 12(1):24-38. PubMed ID: 7724485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives.
    Sashidhara KV; Kumar A; Kumar M; Srivastava A; Puri A
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6504-7. PubMed ID: 20932744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypolipidemic activity of 5-aryl-3-methylvaleric acid derivatives.
    Dygos JH; Jett CM; Chinn LJ; Miller JE
    J Med Chem; 1977 Dec; 20(12):1705-8. PubMed ID: 592342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological studies of 3-amino-2-methyl-1-phenyl-propanones as hypolipidemic agents in rodents.
    Huang Y; Hall IH
    Arch Pharm (Weinheim); 1996 Jul; 329(7):329-38. PubMed ID: 8764881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo).
    Poplawski J; Lozowicka B; Dubis AT; Lachowska B; Witkowski S; Siluk D; Petrusewicz J; Kaliszan R; Cybulski J; Strzałkowska M; Chilmonczyk Z
    J Med Chem; 2000 Oct; 43(20):3671-6. PubMed ID: 11020281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypolipidemic analogues of ethyl 4-benzyloxybenzoate.
    Baggaley KH; Fears R; Hindley RM; Morgan B; Murrell E; Thorne DE
    J Med Chem; 1977 Nov; 20(11):1388-93. PubMed ID: 915898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of hypolipidemic agents. 1. Synthesis and hypolipidemic activities of alkoxycinnamic acid derivatives.
    Watanabe T; Hayashi K; Yoshimatsu S; Sakai K; Takeyama S; Takashima K
    J Med Chem; 1980 Jan; 23(1):50-9. PubMed ID: 7359513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and hypolipidemic activity of 4-substituted 1-acyl-1,2,4-triazolidine-3,5-diones in rodents.
    Simlot R; Izydore RA; Wong OT; Hall IH
    J Pharm Sci; 1993 Apr; 82(4):408-15. PubMed ID: 8468686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lipid-lowering profile in rodents. AZ-1355, a new dibenzoxazepine derivative.
    Wada S; Koizumi M; Sasahara K; Neichi T; Nakakimura H; Onoda F; Hata SI
    Atherosclerosis; 1981; 40(3-4):263-71. PubMed ID: 7332605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and hypolipidemic activity of N-substituted phthalimides. Part V.
    Sena VL; Srivastava RM; Silva RO; Lima VL
    Farmaco; 2003 Dec; 58(12):1283-8. PubMed ID: 14630240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental hyper-beta-lipoproteinemia and its amelioration by a novel hypolipidemic agent.
    Kobayakawa T; Osuga K; Yasuda H
    Atherosclerosis; 1978 Jul; 30(3):219-25. PubMed ID: 209804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypolipidemic activity of phthalimide derivatives. 2. N-phenylphthalimide and derivatives.
    Chapman JM; Voorstad PJ; Cocolas GH; Hall IH
    J Med Chem; 1983 Feb; 26(2):237-43. PubMed ID: 6131131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypolipidemic arylthioalkanoic acids.
    Wagner ER; Dull RG; Mueller LG; Allen BJ; Renzi AA; Rytter DJ; Barnhart JW; Byers C
    J Med Chem; 1977 Aug; 20(8):1007-13. PubMed ID: 894671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential hypolipidemic agents. 7. Synthesis and lipid-lowering properties of 2-(dibenzofuranyloxy)-2-methylpropionates and related compounds.
    Bondesson G; Hedbom C; Högberg T; Magnusson O; Stjernström NE; Carlson LA
    J Med Chem; 1974 Jan; 17(1):108-12. PubMed ID: 4808456
    [No Abstract]   [Full Text] [Related]  

  • 19. On the effect of 2-deuterium- and 2-methyl-eicosapentaenoic acid derivatives on triglycerides, peroxisomal beta-oxidation and platelet aggregation in rats.
    Willumsen N; Vaagenes H; Holmsen H; Berge RK
    Biochim Biophys Acta; 1998 Mar; 1369(2):193-203. PubMed ID: 9518609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypocholesterolemic and hypolipidemic activity of some novel morpholine derivatives with antioxidant activity.
    Chrysselis MC; Rekka EA; Kourounakis PN
    J Med Chem; 2000 Feb; 43(4):609-12. PubMed ID: 10691687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.